Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3766-3772.
Prepublished online as a Blood First Edition Paper on January 15, 2004; DOI 10.1182/blood-2003-08-2712.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-08-2712v1
103/10/3766    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, S.
Right arrow Articles by Koike, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, S.
Right arrow Articles by Koike, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted August 7, 2003
Accepted January 5, 2004

Nicked beta2-glycoprotein I: A marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis

Shinsuke Yasuda, Tatsuya Atsumi*, Masahiro Ieko, Eiji Matsuura, Kazuko Kobayashi, Junko Inagaki, Hisao Kato, Hideyuki Tanaka, Minoru Yamakado, Minoru Akino, Hisatoshi Saitou, Yoshiharu Amasaki, Satoshi Jodo, Olga Amengual, and Takao Koike

Department of Medicine II, Hokkaido University Graduate School of Medicine, Sapporo, Japan
Department of Internal Medicine, School of Dentistry, Health Sciences University of Hokkaido, Hokkaido, Japan
Department of Cell Chemistry, Institute of Molecular and Cellular Biology, Okayama University Medical School, Okayama, Japan
National Cardiovascular Center Research Institute, Osaka, Japan
Narita R&D Center, Iatron laboratories Inc., Mito, Chiba, Japan
Department of Medicine, Mitsui Memorial Hospital, Tokyo, Japan
Azabu Neurosurgical Hospital, Department of Neurosurgery, Sapporo, Japan

* Corresponding author; email: at3tat{at}med.hokudai.ac.jp.

{beta}2-glycoprotein I ({beta}2GPI) is proteolytically cleaved by plasmin in domain V (nicked {beta}2GPI), being unable to bind to phospholipids. This cleavage may occur in vivo and elevated plasma levels of nicked {beta}2GPI were detected in patients with massive plasmin generation and fibrinolysis turnover. In this study, we reported higher prevalence of elevated ratio of nicked {beta}2GPI against total {beta}2GPI in patients with ischemic stroke (63%) and healthy subjects with lacunar infarct (27%) when compared to healthy subjects with normal MRI findings (8%), suggesting that nicked {beta}2GPI might have a physiological role beyond that of its parent molecule in patients with thrombosis. Several inhibitors of extrinsic fibrinolysis are known, but a negative feedback regulator has not been yet documented. We demonstrated that nicked {beta}2GPI binds to Glu-plasminogen with KD of 0.37 x 10-6 M, presumably mediated by the interaction between the fifth domain of nicked {beta}2GPI and the fifth kringle domain of Glu-plasminogen. Nicked {beta}2GPI also suppressed plasmin generation up to 70% in the presence of tissue plasminogen activator, plasminogen, and fibrin. Intact {beta}2GPI lacks these properties. These data suggest that {beta}2GPI/plasmin-nicked {beta}2GPI control extrinsic fibrinolysis via a negative feedback pathway loop.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
H. Nakagawa, S. Yasuda, E. Matsuura, K. Kobayashi, M. Ieko, H. Kataoka, T. Horita, T. Atsumi, and T. Koike
Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property
Blood, September 17, 2009; 114(12): 2553 - 2559.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
R Forastiero and M Martinuzzo
Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 872 - 877.
[Abstract] [PDF]


Home page
LupusHome page
E Cockrell, R. Espinola, and K. McCrae
Annexin A2: biology and relevance to the antiphospholipid syndrome
Lupus, October 1, 2008; 17(10): 944 - 952.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
T. Sakai, K. Balasubramanian, S. Maiti, J. B. Halder, and A. J. Schroit
Plasmin-Cleaved {beta}-2-Glycoprotein 1 Is an Inhibitor of Angiogenesis
Am. J. Pathol., November 1, 2007; 171(5): 1659 - 1669.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Giannakopoulos, F. Passam, S. Rahgozar, and S. A. Krilis
Current concepts on the pathogenesis of the antiphospholipid syndrome
Blood, January 15, 2007; 109(2): 422 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shi, B. Giannakopoulos, G. M. Iverson, K. A. Cockerill, M. D. Linnik, and S. A. Krilis
Domain V of {beta}2-Glycoprotein I Binds Factor XI/XIa and Is Cleaved at Lys317-Thr318
J. Biol. Chem., January 14, 2005; 280(2): 907 - 912.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020